Better health. Within reach. Every day. Hikma Farmacutica - - PowerPoint PPT Presentation

better health
SMART_READER_LITE
LIVE PREVIEW

Better health. Within reach. Every day. Hikma Farmacutica - - PowerPoint PPT Presentation

Better health. Within reach. Every day. Hikma Farmacutica (Portugal), S.A. Sintra 26/Out/2018 Hikma in the World Fact sheet 2 Hikma in the World Global footprint INJECTABLES Selling specialized generic and branded injectable products


slide-1
SLIDE 1

Better health. Within reach. Every day.

Hikma Farmacêutica (Portugal), S.A.

Sintra 26/Out/2018

slide-2
SLIDE 2

Hikma in the World

Fact sheet

2

slide-3
SLIDE 3

INJECTABLES

Selling specialized generic and branded injectable products globally

3

Hikma in the World

Global footprint

$776m

40%*

*Hikma group business volume, 2017

BRANDED

Selling branded generics and in-licensed products across the MENA region

$536m

28%*

GENERICS

Selling non-injectable generic products across the US

$615m

32%*

Manufacturing facility R&D centre

slide-4
SLIDE 4

4

Hikma in Portugal

Multinational company deeply committed to Sintra 29 years in Portugal

(in Sintra since 1991)

we sell to 13 countries worldwide

(creating value through exports)

  • ur products are used
  • nly in hospitals

>620 employees

(+50 open positions)

Portugal is the center of excellence of our Injectables division we contribute to science and innovation we have unique

  • perational capabilities

major impact in local community

(60% workforce is from Sintra)

slide-5
SLIDE 5

5

Hikma in Portugal

Local company with a global reach

8 7 10 12 15 28 26 28 33 36 40 47 71 67 71 86 101 107 9 9 11 14 17 30 29 32 37 41 44 52 76 71 76 92 107 114 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Exportações Vendas

  • Creating value through exports - over 93% of the total turnover comes from international markets.
  • In the last 5y the total exports surpassed 430M EUR.

18% 23% 59% MENA EU US

Exports Total Sales

slide-6
SLIDE 6

7 12 13 11 12 398 479 498 552 626

  • 2

4 6 8 10 12 14 16 18 50 100 150 200 250 300 350 400 450 500 550 600 650 2014 2015 2016 2017 2018

6

Hikma in Portugal

+51 M EUR

investment last 5y

Continuous investment and growth

+228 jobs

created since 2014

  • Continuous investment in the expansion and modernization of the industrial campus in Sintra;
  • In the last 5 years, more than 225 new jobs have been created;
  • A young workforce (72% of our employees are between 20 and 40 years old) and qualified (37% of the employees have higher education).

Nº of employees investment (m€)

slide-7
SLIDE 7

7

►the 1st facility specialized in Oncology medicines in Portugal ►among the TOP 5 biggest Oncology facilities in EU ►new state of the art equipment, with multiple technologies for different drug formats ►98% dedicated to export business ►creation of 80 new jobs ►expected launch date mid 2019.

Hikma in Portugal

the new Oncology facility

slide-8
SLIDE 8

8

Hikma in Portugal

the new R&D center

►Hikma will establish a state-of-the-art Pharmaceutical R&D facility in Portugal, in our Sintra site; ►the center will have fully equipped labs and a high-end pilot plant; ►this will create highly skilled jobs, approximately 20 scientists; ►team will work on injectables products: vials, bags, pre-filled syringes and complex injectables; ►Project will start in early 2019

slide-9
SLIDE 9

9

Hikma in Portugal

an active member of the local community

►In Hikma we are truly committed to playing a role in the community ►we have a strong Corporate Social Responsibility program that is aimed to give back, helping the communities in which we live and work through several initiatives:

  • Volunteering day – IPO, Santa Casa da Misericórdia de Sintra
  • Donations
  • Promoting Inclusivity through Employment – refugees
  • Sponsorship of sporting events
slide-10
SLIDE 10

Within reach. Better health. Every day.

1 second = 1 day = 1M

10

slide-11
SLIDE 11

Hikma Pharmaceuticals PLC

Better health. Within Reach. Everyday.

OBRIGADO